Financials
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses ——————— — Research & development ——————— — Operating income 799 M413 M716 M517 M923 M552 M714 M 2.71 B Non-Operating Income, Total 1 M37 M11 M36 M-210 M52 M-22 M -144 M Interest expense, net of interest capitalized ——————— — Non-Operating Income, excl. Interest Expenses -15 M20 M-1 M7 M-244 M8 M-33 M -262 M Unusual income/expense 16 M17 M12 M29 M34 M44 M11 M 118 M Pretax income 529 M170 M434 M246 M397 M295 M384 M 1.32 B Equity in earnings ——————— — Taxes ——————— — Non-controlling/minority interest ——————— — After tax other income/expense ——————— — Net income before discontinued operations 829 M125 M408 M212 M615 M266 M392 M 1.49 B Discontinued operations ——————— — Net income 829 M125 M408 M212 M615 M266 M392 M 1.49 B Dilution adjustment ——————— — Preferred dividends ——————— — Diluted net income available to common stockholders 829 M125 M408 M212 M615 M266 M392 M 1.49 B Basic earnings per share (Basic EPS) ——————— — Diluted earnings per share (Diluted EPS) ——————— — Average basic shares outstanding ——————— — Diluted shares outstanding ——————— — EBITDA 1.36 B1.04 B1.31 B1.13 B1.55 B894 M962 M 4.53 B EBIT 799 M125 M716 M517 M923 M266 M392 M 2.1 B Cost of revenue ——————— — Other cost of goods sold ——————— — Depreciation & amortization (cash flow) 564 M623 M594 M608 M625 M628 M570 M 2.43 B